Alembic Pharmaceuticals informs about press release

05 May 2021 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5%. In this regard, the company has enclosed a press release on 5th May 2021.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

770.55 7.65 (1.00%)
23-Feb-2026 14:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1730.45
Dr. Reddys Lab 1304.30
Cipla 1323.65
Zydus Lifesciences 903.45
Lupin 2235.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×